AFT Pharmaceuticals

AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital. AFT's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.

Company Details

Registered Office: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622

Postal Address: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622

Telephone: +64 9 488 0232

Facsimile: n/a

Website: www.aftpharm.com

First Listed: 22/12/2015

Balance Date: 31 March

AGM: 04/08/2023

Directors and Executives

Hartley Atkinson

Executive Director

Marree Atkinson

Executive Director

Anita Baldauf

Independent Director

David Flacks

Chairman

Andrew Lane

Director

Malcolm Tubby

CFO / Company Secretary

Ted Witek

Independent Non-Executive Director

Announcements

Title	Date	Type
AFT,Massey Ventures,Gilles McIndoe to develop scar treatmen	Wed, Apr 24 2024 08:30 am	GENERAL
AFT makes further progress in international markets	Mon, Mar 04 2024 08:48 am	GENERAL
AFT updates operating profit guidance to $23m to $25m	Fri, Feb 16 2024 08:30 am	GENERAL
Maxigesic IV launched in the United States	Wed, Feb 07 2024 08:30 am	GENERAL
AFT further broadens R&D pipeline with new product	Fri, Jan 19 2024 08:34 am	GENERAL
NEW YEAR LETTER TO INVESTORS	Tue, Jan 09 2024 08:30 am	GENERAL
AFT broadens R&D pipeline with new product candidate	Fri, Dec 22 2023 08:49 am	GENERAL
AFT Pharma reports growth and global expansion	Thu, Nov 23 2023 08:34 am	HALFYR
AFT’s Crystaderm® antiseptic approved for sale in China	Tue, Nov 21 2023 08:30 am	GENERAL
AFT welcomes US FDA approval for sale of Maxigesic IV	Wed, Oct 18 2023 08:30 am	GENERAL

Major Holdings Announcements

Date	Name	No. Held	%	Current
16/09/20	Forsyth Barr Group Limited and Fors	1,617,818	71.25	1.55
15/06/20	Hartley Campbell Atkinson and Colin	72,031,609	72.60	69.82
15/06/20	The CRG Persons	-	15.99	-
25/05/17	AFT Pharmaceuticals Limited	-	72.34	-

Director’s Interests Announcements

Date	Name	No. Held	%	Details	Other
18/09/23	Jon Lamb	271,314	-	-	-
14/04/21	Malcolm Tubby	143,892	-	-	-
10/08/20	Hartley Atkinson	72,899,435	-	-	-
03/07/20	David Flacks	178,764	-	-	-
22/08/18	James Burns	125,417	-	-	-
19/06/17	John Douglas Wilson	56,689	-	-	-

Analysts’ Forecasts

	profit2021	profit2022	eps2021	dps2021	sales2021	ebit2021	ebitda2021
mean	13.7	13.1	2.0	191.3	22.0	24.6
high	13.7	13.1	2.0	191.3	22.0	24.6
low	13.7	13.1	2.0	191.3	22.0	24.6
sample	1	0	1	1	1	1	1

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.

Last Updated: 04/07/2023